Cargando…

Efficacy and Safety of Risankizumab in Hidradenitis Suppurativa: A Case Series

Detalles Bibliográficos
Autores principales:	REPETTO, Federica, BURZI, Lorenza, RIBERO, Simone, QUAGLINO, Pietro, DAPAVO, Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Society for Publication of Acta Dermato-Venereologica 2022
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677263/ https://www.ncbi.nlm.nih.gov/pubmed/35971829 http://dx.doi.org/10.2340/actadv.v102.2926

Ejemplares similares

Drug Survival of Anti Interleukin-17 and Interleukin -23 Agents after Adalimumab Failure in Hidradenitis Suppurativa: A Pilot Study
por: REPETTO, Federica, et al.
Publicado: (2023)

Switching from adalimumab originator to biosimilars in hidradenitis suppurativa: What's beyond cost‐effectiveness?
por: Roccuzzo, Gabriele, et al.
Publicado: (2022)

Paradoxical psoriasiform reactions during treatment with adalimumab for hidradenitis suppurativa: Real‐life experience and therapeutic response to other biological drugs
por: Burzi, Lorenza, et al.
Publicado: (2022)

Risankizumab shows high efficacy and maintenance in improvement of response until week 52
por: Mastorino, Luca, et al.
Publicado: (2022)

Efficacy and Safety of Risankizumab for the Treatment of Hidradenitis Suppurativa: A Phase 2, Randomized, Placebo-Controlled Trial
por: Kimball, Alexa B., et al.
Publicado: (2023)

Efficacy and Safety of Secukinumab in Patients with Plaque Psoriasis and Latent Tuberculosis
por: Ribero, Simone, et al.
Publicado: (2019)

Impact of Bariatric Surgery on Hidradenitis Suppurativa
por: CANARD, Clothilde, et al.
Publicado: (2021)

Hidradenitis Suppurativa Prevalence in Nuuk, Greenland: Physician Validation of a Hidradenitis Suppurativa Questionnaire in a Greenlandic Setting
por: BOTVID, Sofia H. C., et al.
Publicado: (2023)

Effect of Hidradenitis Suppurativa Disease Duration on Psychiatric Comorbidity
por: TIRI, Hannu, et al.
Publicado: (2020)

Lambert-Eaton Myasthenic Syndrome and Paraneoplastic Cerebellar Degeneration Associated with Merkel Cell Carcinoma with Unknown Primary: A Case Report
por: AGOSTINI, Andrea, et al.
Publicado: (2021)

Assessing Pruritus in Hidradenitis Suppurativa: A Cross-Sectional Study
por: Vossen, Allard R. J. V., et al.
Publicado: (2017)

Retrospective Cohort Study on Asian Patients with Hidradenitis Suppurativa: Factors Associated with the Efficacy of Antibiotic Treatment
por: JANG, Yun Kyung, et al.
Publicado: (2022)

Guselkumab, Risankizumab, and Tildrakizumab in the Management of Hidradenitis Suppurativa: A Review of Existing Trials and Real-Life Data
por: Martora, Fabrizio, et al.
Publicado: (2023)

Role of teledermatology in the management of dermatological diseases among marine workers: A cross-sectional study comparing general practitioners and dermatological diagnoses
por: Di Canio, Marzio, et al.
Publicado: (2022)

Safety of Adalimumab Dosed Every Week and Every Other Week: Focus on Patients with Hidradenitis Suppurativa or Psoriasis
por: Ryan, Caitriona, et al.
Publicado: (2018)

Paradoxical Reaction in a Patient with Hidradenitis Suppurativa Undergoing Adalimumab Treatment
por: IKEYA, Soichiro, et al.
Publicado: (2021)

Allergic Contact Dermatitis to Topical Clindamycin in a Patient with Hidradenitis Suppurativa
por: PAHLOW MOSE, Anja, et al.
Publicado: (2022)

Improved Psychosocial Status after Surgery for Genital Elephantiasis due to Hidradenitis Suppurativa: A Prospective Study of a Case Series
por: LELONEK, Edyta, et al.
Publicado: (2021)

A Novel NCSTN Gene Mutation in a Japanese Family with Hidradenitis Suppurativa
por: NISHIMORI, Nobuyuki, et al.
Publicado: (2020)

Hidradenitis suppurativa: retrospective study of 20 cases*
por: Fernandes, Nurimar Conceição, et al.
Publicado: (2013)

The efficacy and safety of endo‐radiofrequency for the treatment of hidradenitis suppurativa
por: Behrangi, Elham, et al.
Publicado: (2023)

LAight(®) Therapy Improves Hidradenitis Suppurativa in Patients Declining Surgical Intervention: Two Case Reports
por: BISSCHOFF, Izak Johannes, et al.
Publicado: (2020)

Overall Impairment of Quality of Life in Japanese Patients with Hidradenitis Suppurativa: Comparison with National Standard
por: HAYAMA, Koremasa, et al.
Publicado: (2022)

Prevalence and Associated Factors of Alexithymia in Patients with Hidradenitis Suppurativa: A Cross-sectional Study
por: GŁOWACZEWSKA, Amelia, et al.
Publicado: (2021)

Neoadjuvant Biologic Therapy in the Surgical Management of Patients with Hidradenitis Suppurativa: A Cohort Study
por: SALVADOR-RODRIGUEZ, Luis, et al.
Publicado: (2020)

Hidradenitis suppurativa and psoriasis: the odd couple
por: Macca, Laura, et al.
Publicado: (2023)

Hidradenitis suppurativa and adalimumab in the COVID-19 era
por: Marzano, Angelo Valerio, et al.
Publicado: (2021)

Biologic Therapy for Hidradenitis Suppurativa Plus Conglobate Acne Associated with SAPHO Syndrome: A Case Report
por: BRIEDE, Kamilija, et al.
Publicado: (2020)

Cutaneous Events Associated with Immunotherapy of Melanoma: A Review
por: Burzi, Lorenza, et al.
Publicado: (2021)

Risk factors for hidradenitis suppurativa: a pilot study()
por: Schmitt, Juliano Vilaverde, et al.
Publicado: (2012)

Antibiotic Treatment for Hidradenitis Suppurativa in France: A Practice Survey
por: Fougerousse, Anne-Claire, et al.
Publicado: (2022)

Botulinum Toxin Type B for Hidradenitis Suppurativa: A Randomised, Double-Blind, Placebo-Controlled Pilot Study
por: Grimstad, Øystein, et al.
Publicado: (2020)

Similar Levels of Disease Severity Correspond to a Greater Burden of Illness in Women Compared with Men with Hidradenitis Suppurativa
por: SAMELA, Tonia, et al.
Publicado: (2023)

Hidradenitis suppurativa in AIDS
por: Khambhati, Ravi, et al.
Publicado: (2010)

Hidradenitis suppurativa and intimacy
por: Jemec, G.
Publicado: (2018)

Coexistence of Hidradenitis Suppurativa and Steatocystoma Multiplex: Is It a New Variant of Hidradenitis Suppurativa?
por: Fletcher, Joshua, et al.
Publicado: (2021)

Efficacy and safety of topical resorcinol 15% versus topical clindamycin 1% in the management of mild‐to‐moderate hidradenitis suppurativa: A retrospective study
por: Molinelli, Elisa, et al.
Publicado: (2022)

Guselkumab shows high efficacy and maintenance in the improvement of response until week 48, a real‐life study
por: Mastorino, Luca, et al.
Publicado: (2022)

Multidisciplinary Management of Adolescents with Hidradenitis Suppurativa – Series of Cases and Literature Review
por: Țarcă, Elena, et al.
Publicado: (2021)

Surgical Management of Hidradenitis Suppurativa
por: Menderes, Adnan, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_alku4qn9mo5uubkre59da84eq7